ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Compound Andrographis Paniculata Tablets Market Research Report 2026
Published Date: 2026-01-28
|
Report Code: QYRE-Auto-33J18522
Home | Market Reports | Health| Nutrition| Vitamins & Supplements
Global Compound Andrographis Paniculata Tablets Market Research Report 2024
BUY CHAPTERS

Global Compound Andrographis Paniculata Tablets Market Research Report 2026

Code: QYRE-Auto-33J18522
Report
2026-01-28
Pages:128
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Teyi Pharmaceutical Group Co.,Ltd.
Guangxi Chanfang Pharmaceutical Co., Ltd.
Hefei Cube Pharmaceutical Co., Ltd.
Sichuan Tiande Pharmaceutical Co., Ltd.
Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd.
Sichuan Everbright Pharmaceutical Co., Ltd.
Sichuan Tianji Biopharmaceutical Co., Ltd.
Sichuan Tongyuan Pharmaceutical Group Co., Ltd.
Huizhou Daya Pharmaceutical Co., Ltd.
Sichuan Senke Pharmaceutical Co., Ltd.
Baotou Traditional Chinese Medicine Co., Ltd.
Guangdong Hengcheng Pharmaceutical Co., Ltd.
Henan Lingrui Pharmaceutical Co., Ltd.
Zhongshan Kekekang Pharmaceutical Co., Ltd.
Sanmenxia Guangyu Biopharmaceutical Co., Ltd.
Yunnan Dai Medicine Co., Ltd.
Luoyang Homeopathic Pharmaceutical Co., Ltd.
Guangxi Beibu Gulf Pharmaceutical Co., Ltd.
Guangxi Jinye Pharmaceutical Co., Ltd.
Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd.

Compound Andrographis Paniculata Tablets Market Size

The global Compound Andrographis Paniculata Tablets market was valued at US$ 97 million in 2025 and is anticipated to reach US$ 144 million by 2032, at a CAGR of 5.9% from 2026 to 2032.

Compound Andrographis Paniculata Tablets Market

Compound Andrographis Paniculata Tablets Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Compound Andrographis Paniculata Tablets competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Compound Andrographis paniculata Tablets are over-the-counter drugs for throat diseases. Its main ingredient is Andrographis paniculata. Andrographis paniculata has the effects of clearing away heat and detoxification, anti-inflammatory, swelling and pain relief. It is mainly used to treat bacterial dysentery, urinary tract infection and acute tonsillitis.
The North American market for Compound Andrographis Paniculata Tablets is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Compound Andrographis Paniculata Tablets is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Compound Andrographis Paniculata Tablets include Teyi Pharmaceutical Group Co., Ltd., Sanmenxia Guangyu Biopharmaceutical Co., Ltd., Guangxi Chanfang Pharmaceutical Co., Ltd., Hefei Cube Pharmaceutical Co., Ltd., Sichuan Tiande Pharmaceutical Co., Ltd., Yunnan Dai Medicine Co., Ltd., Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd., Luoyang Homeopathic Pharmaceutical Co., Ltd., Sichuan Everbright Pharmaceutical Co., Ltd., Guangxi Beibu Gulf Pharmaceutical Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Compound Andrographis Paniculata Tablets market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Compound Andrographis Paniculata Tablets. The Compound Andrographis Paniculata Tablets market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Compound Andrographis Paniculata Tablets market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Compound Andrographis Paniculata Tablets manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Compound Andrographis Paniculata Tablets Market Report

Report Metric Details
Report Name Compound Andrographis Paniculata Tablets Market
Accounted market size in 2025 US$ 97 million
Forecasted market size in 2032 US$ 144 million
CAGR 5.9%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Film-coated Tablets
  • Sugar-coated Tablets
by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Teyi Pharmaceutical Group Co., Ltd., Sanmenxia Guangyu Biopharmaceutical Co., Ltd., Guangxi Chanfang Pharmaceutical Co., Ltd., Hefei Cube Pharmaceutical Co., Ltd., Sichuan Tiande Pharmaceutical Co., Ltd., Yunnan Dai Medicine Co., Ltd., Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd., Luoyang Homeopathic Pharmaceutical Co., Ltd., Sichuan Everbright Pharmaceutical Co., Ltd., Guangxi Beibu Gulf Pharmaceutical Co., Ltd., Sichuan Tianji Biopharmaceutical Co., Ltd., Sichuan Tongyuan Pharmaceutical Group Co., Ltd., Huizhou Daya Pharmaceutical Co., Ltd., Sichuan Senke Pharmaceutical Co., Ltd., Baotou Traditional Chinese Medicine Co., Ltd., Guangxi Jinye Pharmaceutical Co., Ltd., Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd., Guangdong Hengcheng Pharmaceutical Co., Ltd., Henan Lingrui Pharmaceutical Co., Ltd., Zhongshan Kekekang Pharmaceutical Co., Ltd.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Compound Andrographis Paniculata Tablets manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Compound Andrographis Paniculata Tablets sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Compound Andrographis Paniculata Tablets Market growing?

Ans: The Compound Andrographis Paniculata Tablets Market witnessing a CAGR of 5.9% during the forecast period 2026-2032.

What is the Compound Andrographis Paniculata Tablets Market size in 2032?

Ans: The Compound Andrographis Paniculata Tablets Market size in 2032 will be US$ 144 million.

Who are the main players in the Compound Andrographis Paniculata Tablets Market report?

Ans: The main players in the Compound Andrographis Paniculata Tablets Market are Teyi Pharmaceutical Group Co., Ltd., Sanmenxia Guangyu Biopharmaceutical Co., Ltd., Guangxi Chanfang Pharmaceutical Co., Ltd., Hefei Cube Pharmaceutical Co., Ltd., Sichuan Tiande Pharmaceutical Co., Ltd., Yunnan Dai Medicine Co., Ltd., Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd., Luoyang Homeopathic Pharmaceutical Co., Ltd., Sichuan Everbright Pharmaceutical Co., Ltd., Guangxi Beibu Gulf Pharmaceutical Co., Ltd., Sichuan Tianji Biopharmaceutical Co., Ltd., Sichuan Tongyuan Pharmaceutical Group Co., Ltd., Huizhou Daya Pharmaceutical Co., Ltd., Sichuan Senke Pharmaceutical Co., Ltd., Baotou Traditional Chinese Medicine Co., Ltd., Guangxi Jinye Pharmaceutical Co., Ltd., Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd., Guangdong Hengcheng Pharmaceutical Co., Ltd., Henan Lingrui Pharmaceutical Co., Ltd., Zhongshan Kekekang Pharmaceutical Co., Ltd.

What are the Application segmentation covered in the Compound Andrographis Paniculata Tablets Market report?

Ans: The Applications covered in the Compound Andrographis Paniculata Tablets Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Compound Andrographis Paniculata Tablets Market report?

Ans: The Types covered in the Compound Andrographis Paniculata Tablets Market report are Film-coated Tablets, Sugar-coated Tablets

1 Compound Andrographis Paniculata Tablets Market Overview
1.1 Product Definition
1.2 Compound Andrographis Paniculata Tablets by Type
1.2.1 Global Compound Andrographis Paniculata Tablets Market Value by Type: 2025 vs 2032
1.2.2 Film-coated Tablets
1.2.3 Sugar-coated Tablets
1.3 Compound Andrographis Paniculata Tablets by Application
1.3.1 Global Compound Andrographis Paniculata Tablets Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Compound Andrographis Paniculata Tablets Market Size Estimates and Forecasts
1.4.1 Global Compound Andrographis Paniculata Tablets Revenue 2021–2032
1.4.2 Global Compound Andrographis Paniculata Tablets Sales 2021–2032
1.4.3 Global Compound Andrographis Paniculata Tablets Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Compound Andrographis Paniculata Tablets Market Competition by Manufacturers
2.1 Global Compound Andrographis Paniculata Tablets Sales Market Share by Manufacturers (2021–2026)
2.2 Global Compound Andrographis Paniculata Tablets Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Compound Andrographis Paniculata Tablets Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Compound Andrographis Paniculata Tablets, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Compound Andrographis Paniculata Tablets, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Compound Andrographis Paniculata Tablets, Product Types and Applications
2.7 Global Key Manufacturers of Compound Andrographis Paniculata Tablets, Date of Entry into the Industry
2.8 Global Compound Andrographis Paniculata Tablets Market Competitive Situation and Trends
2.8.1 Global Compound Andrographis Paniculata Tablets Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Compound Andrographis Paniculata Tablets Players Market Share by Revenue
2.8.3 Global Compound Andrographis Paniculata Tablets Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Compound Andrographis Paniculata Tablets Market Scenario by Region
3.1 Global Compound Andrographis Paniculata Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Compound Andrographis Paniculata Tablets Sales by Region: 2021–2032
3.2.1 Global Compound Andrographis Paniculata Tablets Sales by Region: 2021–2026
3.2.2 Global Compound Andrographis Paniculata Tablets Sales by Region: 2027–2032
3.3 Global Compound Andrographis Paniculata Tablets Revenue by Region: 2021–2032
3.3.1 Global Compound Andrographis Paniculata Tablets Revenue by Region: 2021–2026
3.3.2 Global Compound Andrographis Paniculata Tablets Revenue by Region: 2027–2032
3.4 North America Compound Andrographis Paniculata Tablets Market Facts & Figures by Country
3.4.1 North America Compound Andrographis Paniculata Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Compound Andrographis Paniculata Tablets Sales by Country (2021–2032)
3.4.3 North America Compound Andrographis Paniculata Tablets Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Compound Andrographis Paniculata Tablets Market Facts & Figures by Country
3.5.1 Europe Compound Andrographis Paniculata Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Compound Andrographis Paniculata Tablets Sales by Country (2021–2032)
3.5.3 Europe Compound Andrographis Paniculata Tablets Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Compound Andrographis Paniculata Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Compound Andrographis Paniculata Tablets Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Compound Andrographis Paniculata Tablets Sales by Region (2021–2032)
3.6.3 Asia Pacific Compound Andrographis Paniculata Tablets Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Compound Andrographis Paniculata Tablets Market Facts & Figures by Country
3.7.1 Latin America Compound Andrographis Paniculata Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Compound Andrographis Paniculata Tablets Sales by Country (2021–2032)
3.7.3 Latin America Compound Andrographis Paniculata Tablets Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Compound Andrographis Paniculata Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Compound Andrographis Paniculata Tablets Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Compound Andrographis Paniculata Tablets Sales by Country (2021–2032)
3.8.3 Middle East and Africa Compound Andrographis Paniculata Tablets Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Compound Andrographis Paniculata Tablets Sales by Type (2021–2032)
4.1.1 Global Compound Andrographis Paniculata Tablets Sales by Type (2021–2026)
4.1.2 Global Compound Andrographis Paniculata Tablets Sales by Type (2027–2032)
4.1.3 Global Compound Andrographis Paniculata Tablets Sales Market Share by Type (2021–2032)
4.2 Global Compound Andrographis Paniculata Tablets Revenue by Type (2021–2032)
4.2.1 Global Compound Andrographis Paniculata Tablets Revenue by Type (2021–2026)
4.2.2 Global Compound Andrographis Paniculata Tablets Revenue by Type (2027–2032)
4.2.3 Global Compound Andrographis Paniculata Tablets Revenue Market Share by Type (2021–2032)
4.3 Global Compound Andrographis Paniculata Tablets Price by Type (2021–2032)
5 Segment by Application
5.1 Global Compound Andrographis Paniculata Tablets Sales by Application (2021–2032)
5.1.1 Global Compound Andrographis Paniculata Tablets Sales by Application (2021–2026)
5.1.2 Global Compound Andrographis Paniculata Tablets Sales by Application (2027–2032)
5.1.3 Global Compound Andrographis Paniculata Tablets Sales Market Share by Application (2021–2032)
5.2 Global Compound Andrographis Paniculata Tablets Revenue by Application (2021–2032)
5.2.1 Global Compound Andrographis Paniculata Tablets Revenue by Application (2021–2026)
5.2.2 Global Compound Andrographis Paniculata Tablets Revenue by Application (2027–2032)
5.2.3 Global Compound Andrographis Paniculata Tablets Revenue Market Share by Application (2021–2032)
5.3 Global Compound Andrographis Paniculata Tablets Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Teyi Pharmaceutical Group Co., Ltd.
6.1.1 Teyi Pharmaceutical Group Co., Ltd. Company Information
6.1.2 Teyi Pharmaceutical Group Co., Ltd. Description and Business Overview
6.1.3 Teyi Pharmaceutical Group Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Teyi Pharmaceutical Group Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
6.1.5 Teyi Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.2 Sanmenxia Guangyu Biopharmaceutical Co., Ltd.
6.2.1 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Company Information
6.2.2 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Description and Business Overview
6.2.3 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
6.2.5 Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Guangxi Chanfang Pharmaceutical Co., Ltd.
6.3.1 Guangxi Chanfang Pharmaceutical Co., Ltd. Company Information
6.3.2 Guangxi Chanfang Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Guangxi Chanfang Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Guangxi Chanfang Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
6.3.5 Guangxi Chanfang Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Hefei Cube Pharmaceutical Co., Ltd.
6.4.1 Hefei Cube Pharmaceutical Co., Ltd. Company Information
6.4.2 Hefei Cube Pharmaceutical Co., Ltd. Description and Business Overview
6.4.3 Hefei Cube Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Hefei Cube Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
6.4.5 Hefei Cube Pharmaceutical Co., Ltd. Recent Developments/Updates
6.5 Sichuan Tiande Pharmaceutical Co., Ltd.
6.5.1 Sichuan Tiande Pharmaceutical Co., Ltd. Company Information
6.5.2 Sichuan Tiande Pharmaceutical Co., Ltd. Description and Business Overview
6.5.3 Sichuan Tiande Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Sichuan Tiande Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
6.5.5 Sichuan Tiande Pharmaceutical Co., Ltd. Recent Developments/Updates
6.6 Yunnan Dai Medicine Co., Ltd.
6.6.1 Yunnan Dai Medicine Co., Ltd. Company Information
6.6.2 Yunnan Dai Medicine Co., Ltd. Description and Business Overview
6.6.3 Yunnan Dai Medicine Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Yunnan Dai Medicine Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
6.6.5 Yunnan Dai Medicine Co., Ltd. Recent Developments/Updates
6.7 Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd.
6.7.1 Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd. Company Information
6.7.2 Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd. Description and Business Overview
6.7.3 Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
6.7.5 Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd. Recent Developments/Updates
6.8 Luoyang Homeopathic Pharmaceutical Co., Ltd.
6.8.1 Luoyang Homeopathic Pharmaceutical Co., Ltd. Company Information
6.8.2 Luoyang Homeopathic Pharmaceutical Co., Ltd. Description and Business Overview
6.8.3 Luoyang Homeopathic Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Luoyang Homeopathic Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
6.8.5 Luoyang Homeopathic Pharmaceutical Co., Ltd. Recent Developments/Updates
6.9 Sichuan Everbright Pharmaceutical Co., Ltd.
6.9.1 Sichuan Everbright Pharmaceutical Co., Ltd. Company Information
6.9.2 Sichuan Everbright Pharmaceutical Co., Ltd. Description and Business Overview
6.9.3 Sichuan Everbright Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Sichuan Everbright Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
6.9.5 Sichuan Everbright Pharmaceutical Co., Ltd. Recent Developments/Updates
6.10 Guangxi Beibu Gulf Pharmaceutical Co., Ltd.
6.10.1 Guangxi Beibu Gulf Pharmaceutical Co., Ltd. Company Information
6.10.2 Guangxi Beibu Gulf Pharmaceutical Co., Ltd. Description and Business Overview
6.10.3 Guangxi Beibu Gulf Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Guangxi Beibu Gulf Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
6.10.5 Guangxi Beibu Gulf Pharmaceutical Co., Ltd. Recent Developments/Updates
6.11 Sichuan Tianji Biopharmaceutical Co., Ltd.
6.11.1 Sichuan Tianji Biopharmaceutical Co., Ltd. Company Information
6.11.2 Sichuan Tianji Biopharmaceutical Co., Ltd. Description and Business Overview
6.11.3 Sichuan Tianji Biopharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Sichuan Tianji Biopharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
6.11.5 Sichuan Tianji Biopharmaceutical Co., Ltd. Recent Developments/Updates
6.12 Sichuan Tongyuan Pharmaceutical Group Co., Ltd.
6.12.1 Sichuan Tongyuan Pharmaceutical Group Co., Ltd. Company Information
6.12.2 Sichuan Tongyuan Pharmaceutical Group Co., Ltd. Description and Business Overview
6.12.3 Sichuan Tongyuan Pharmaceutical Group Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Sichuan Tongyuan Pharmaceutical Group Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
6.12.5 Sichuan Tongyuan Pharmaceutical Group Co., Ltd. Recent Developments/Updates
6.13 Huizhou Daya Pharmaceutical Co., Ltd.
6.13.1 Huizhou Daya Pharmaceutical Co., Ltd. Company Information
6.13.2 Huizhou Daya Pharmaceutical Co., Ltd. Description and Business Overview
6.13.3 Huizhou Daya Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Huizhou Daya Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
6.13.5 Huizhou Daya Pharmaceutical Co., Ltd. Recent Developments/Updates
6.14 Sichuan Senke Pharmaceutical Co., Ltd.
6.14.1 Sichuan Senke Pharmaceutical Co., Ltd. Company Information
6.14.2 Sichuan Senke Pharmaceutical Co., Ltd. Description and Business Overview
6.14.3 Sichuan Senke Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Sichuan Senke Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
6.14.5 Sichuan Senke Pharmaceutical Co., Ltd. Recent Developments/Updates
6.15 Baotou Traditional Chinese Medicine Co., Ltd.
6.15.1 Baotou Traditional Chinese Medicine Co., Ltd. Company Information
6.15.2 Baotou Traditional Chinese Medicine Co., Ltd. Description and Business Overview
6.15.3 Baotou Traditional Chinese Medicine Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Baotou Traditional Chinese Medicine Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
6.15.5 Baotou Traditional Chinese Medicine Co., Ltd. Recent Developments/Updates
6.16 Guangxi Jinye Pharmaceutical Co., Ltd.
6.16.1 Guangxi Jinye Pharmaceutical Co., Ltd. Company Information
6.16.2 Guangxi Jinye Pharmaceutical Co., Ltd. Description and Business Overview
6.16.3 Guangxi Jinye Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Guangxi Jinye Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
6.16.5 Guangxi Jinye Pharmaceutical Co., Ltd. Recent Developments/Updates
6.17 Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd.
6.17.1 Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd. Company Information
6.17.2 Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd. Description and Business Overview
6.17.3 Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
6.17.5 Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd. Recent Developments/Updates
6.18 Guangdong Hengcheng Pharmaceutical Co., Ltd.
6.18.1 Guangdong Hengcheng Pharmaceutical Co., Ltd. Company Information
6.18.2 Guangdong Hengcheng Pharmaceutical Co., Ltd. Description and Business Overview
6.18.3 Guangdong Hengcheng Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Guangdong Hengcheng Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
6.18.5 Guangdong Hengcheng Pharmaceutical Co., Ltd. Recent Developments/Updates
6.19 Henan Lingrui Pharmaceutical Co., Ltd.
6.19.1 Henan Lingrui Pharmaceutical Co., Ltd. Company Information
6.19.2 Henan Lingrui Pharmaceutical Co., Ltd. Description and Business Overview
6.19.3 Henan Lingrui Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Henan Lingrui Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
6.19.5 Henan Lingrui Pharmaceutical Co., Ltd. Recent Developments/Updates
6.20 Zhongshan Kekekang Pharmaceutical Co., Ltd.
6.20.1 Zhongshan Kekekang Pharmaceutical Co., Ltd. Company Information
6.20.2 Zhongshan Kekekang Pharmaceutical Co., Ltd. Description and Business Overview
6.20.3 Zhongshan Kekekang Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 Zhongshan Kekekang Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product Portfolio
6.20.5 Zhongshan Kekekang Pharmaceutical Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Compound Andrographis Paniculata Tablets Industry Chain Analysis
7.2 Compound Andrographis Paniculata Tablets Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Compound Andrographis Paniculata Tablets Production Mode & Process Analysis
7.4 Compound Andrographis Paniculata Tablets Sales and Marketing
7.4.1 Compound Andrographis Paniculata Tablets Sales Channels
7.4.2 Compound Andrographis Paniculata Tablets Distributors
7.5 Compound Andrographis Paniculata Tablets Customer Analysis
8 Compound Andrographis Paniculata Tablets Market Dynamics
8.1 Compound Andrographis Paniculata Tablets Industry Trends
8.2 Compound Andrographis Paniculata Tablets Market Drivers
8.3 Compound Andrographis Paniculata Tablets Market Challenges
8.4 Compound Andrographis Paniculata Tablets Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Teyi Pharmaceutical Group Co.,Ltd.
Guangxi Chanfang Pharmaceutical Co., Ltd.
Hefei Cube Pharmaceutical Co., Ltd.
Sichuan Tiande Pharmaceutical Co., Ltd.
Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd.
Sichuan Everbright Pharmaceutical Co., Ltd.
Sichuan Tianji Biopharmaceutical Co., Ltd.
Sichuan Tongyuan Pharmaceutical Group Co., Ltd.
Huizhou Daya Pharmaceutical Co., Ltd.
Sichuan Senke Pharmaceutical Co., Ltd.
Baotou Traditional Chinese Medicine Co., Ltd.
Guangdong Hengcheng Pharmaceutical Co., Ltd.
Henan Lingrui Pharmaceutical Co., Ltd.
Zhongshan Kekekang Pharmaceutical Co., Ltd.
Sanmenxia Guangyu Biopharmaceutical Co., Ltd.
Yunnan Dai Medicine Co., Ltd.
Luoyang Homeopathic Pharmaceutical Co., Ltd.
Guangxi Beibu Gulf Pharmaceutical Co., Ltd.
Guangxi Jinye Pharmaceutical Co., Ltd.
Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd.
List of Tables
 Table 1. Global Compound Andrographis Paniculata Tablets Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Compound Andrographis Paniculata Tablets Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Compound Andrographis Paniculata Tablets Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Compound Andrographis Paniculata Tablets Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Compound Andrographis Paniculata Tablets Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Compound Andrographis Paniculata Tablets Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Compound Andrographis Paniculata Tablets Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Compound Andrographis Paniculata Tablets Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Compound Andrographis Paniculata Tablets, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Compound Andrographis Paniculata Tablets, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Compound Andrographis Paniculata Tablets, Product Types and Applications
 Table 12. Global Key Manufacturers of Compound Andrographis Paniculata Tablets, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Compound Andrographis Paniculata Tablets Companies by Tier (Tier 1, Tier 2, Tier 3), based on Compound Andrographis Paniculata Tablets Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Compound Andrographis Paniculata Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Compound Andrographis Paniculata Tablets Sales by Region (K Units), 2021–2026
 Table 18. Global Compound Andrographis Paniculata Tablets Sales Market Share by Region (2021–2026)
 Table 19. Global Compound Andrographis Paniculata Tablets Sales by Region (K Units), 2027–2032
 Table 20. Global Compound Andrographis Paniculata Tablets Sales Market Share by Region (2027–2032)
 Table 21. Global Compound Andrographis Paniculata Tablets Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Compound Andrographis Paniculata Tablets Revenue Market Share by Region (2021–2026)
 Table 23. Global Compound Andrographis Paniculata Tablets Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Compound Andrographis Paniculata Tablets Revenue Market Share by Region (2027–2032)
 Table 25. North America Compound Andrographis Paniculata Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Compound Andrographis Paniculata Tablets Sales by Country (K Units), 2021–2026
 Table 27. North America Compound Andrographis Paniculata Tablets Sales by Country (K Units), 2027–2032
 Table 28. North America Compound Andrographis Paniculata Tablets Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Compound Andrographis Paniculata Tablets Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Compound Andrographis Paniculata Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Compound Andrographis Paniculata Tablets Sales by Country (K Units), 2021–2026
 Table 32. Europe Compound Andrographis Paniculata Tablets Sales by Country (K Units), 2027–2032
 Table 33. Europe Compound Andrographis Paniculata Tablets Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Compound Andrographis Paniculata Tablets Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Compound Andrographis Paniculata Tablets Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Compound Andrographis Paniculata Tablets Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Compound Andrographis Paniculata Tablets Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Compound Andrographis Paniculata Tablets Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Compound Andrographis Paniculata Tablets Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Compound Andrographis Paniculata Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Compound Andrographis Paniculata Tablets Sales by Country (K Units), 2021–2026
 Table 42. Latin America Compound Andrographis Paniculata Tablets Sales by Country (K Units), 2027–2032
 Table 43. Latin America Compound Andrographis Paniculata Tablets Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Compound Andrographis Paniculata Tablets Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Compound Andrographis Paniculata Tablets Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Compound Andrographis Paniculata Tablets Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Compound Andrographis Paniculata Tablets Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Compound Andrographis Paniculata Tablets Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Compound Andrographis Paniculata Tablets Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Compound Andrographis Paniculata Tablets Sales (K Units) by Type (2021–2026)
 Table 51. Global Compound Andrographis Paniculata Tablets Sales (K Units) by Type (2027–2032)
 Table 52. Global Compound Andrographis Paniculata Tablets Sales Market Share by Type (2021–2026)
 Table 53. Global Compound Andrographis Paniculata Tablets Sales Market Share by Type (2027–2032)
 Table 54. Global Compound Andrographis Paniculata Tablets Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Compound Andrographis Paniculata Tablets Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Compound Andrographis Paniculata Tablets Revenue Market Share by Type (2021–2026)
 Table 57. Global Compound Andrographis Paniculata Tablets Revenue Market Share by Type (2027–2032)
 Table 58. Global Compound Andrographis Paniculata Tablets Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Compound Andrographis Paniculata Tablets Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Compound Andrographis Paniculata Tablets Sales (K Units) by Application (2021–2026)
 Table 61. Global Compound Andrographis Paniculata Tablets Sales (K Units) by Application (2027–2032)
 Table 62. Global Compound Andrographis Paniculata Tablets Sales Market Share by Application (2021–2026)
 Table 63. Global Compound Andrographis Paniculata Tablets Sales Market Share by Application (2027–2032)
 Table 64. Global Compound Andrographis Paniculata Tablets Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Compound Andrographis Paniculata Tablets Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Compound Andrographis Paniculata Tablets Revenue Market Share by Application (2021–2026)
 Table 67. Global Compound Andrographis Paniculata Tablets Revenue Market Share by Application (2027–2032)
 Table 68. Global Compound Andrographis Paniculata Tablets Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Compound Andrographis Paniculata Tablets Price (US$/Unit) by Application (2027–2032)
 Table 70. Teyi Pharmaceutical Group Co., Ltd. Company Information
 Table 71. Teyi Pharmaceutical Group Co., Ltd. Description and Business Overview
 Table 72. Teyi Pharmaceutical Group Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Teyi Pharmaceutical Group Co., Ltd. Compound Andrographis Paniculata Tablets Product
 Table 74. Teyi Pharmaceutical Group Co., Ltd. Recent Developments/Updates
 Table 75. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Company Information
 Table 76. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Description and Business Overview
 Table 77. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product
 Table 79. Sanmenxia Guangyu Biopharmaceutical Co., Ltd. Recent Developments/Updates
 Table 80. Guangxi Chanfang Pharmaceutical Co., Ltd. Company Information
 Table 81. Guangxi Chanfang Pharmaceutical Co., Ltd. Description and Business Overview
 Table 82. Guangxi Chanfang Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Guangxi Chanfang Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product
 Table 84. Guangxi Chanfang Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 85. Hefei Cube Pharmaceutical Co., Ltd. Company Information
 Table 86. Hefei Cube Pharmaceutical Co., Ltd. Description and Business Overview
 Table 87. Hefei Cube Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Hefei Cube Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product
 Table 89. Hefei Cube Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 90. Sichuan Tiande Pharmaceutical Co., Ltd. Company Information
 Table 91. Sichuan Tiande Pharmaceutical Co., Ltd. Description and Business Overview
 Table 92. Sichuan Tiande Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Sichuan Tiande Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product
 Table 94. Sichuan Tiande Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 95. Yunnan Dai Medicine Co., Ltd. Company Information
 Table 96. Yunnan Dai Medicine Co., Ltd. Description and Business Overview
 Table 97. Yunnan Dai Medicine Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Yunnan Dai Medicine Co., Ltd. Compound Andrographis Paniculata Tablets Product
 Table 99. Yunnan Dai Medicine Co., Ltd. Recent Developments/Updates
 Table 100. Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd. Company Information
 Table 101. Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd. Description and Business Overview
 Table 102. Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product
 Table 104. Leshi Tongren Sanmenxia Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 105. Luoyang Homeopathic Pharmaceutical Co., Ltd. Company Information
 Table 106. Luoyang Homeopathic Pharmaceutical Co., Ltd. Description and Business Overview
 Table 107. Luoyang Homeopathic Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Luoyang Homeopathic Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product
 Table 109. Luoyang Homeopathic Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 110. Sichuan Everbright Pharmaceutical Co., Ltd. Company Information
 Table 111. Sichuan Everbright Pharmaceutical Co., Ltd. Description and Business Overview
 Table 112. Sichuan Everbright Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Sichuan Everbright Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product
 Table 114. Sichuan Everbright Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 115. Guangxi Beibu Gulf Pharmaceutical Co., Ltd. Company Information
 Table 116. Guangxi Beibu Gulf Pharmaceutical Co., Ltd. Description and Business Overview
 Table 117. Guangxi Beibu Gulf Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Guangxi Beibu Gulf Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product
 Table 119. Guangxi Beibu Gulf Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 120. Sichuan Tianji Biopharmaceutical Co., Ltd. Company Information
 Table 121. Sichuan Tianji Biopharmaceutical Co., Ltd. Description and Business Overview
 Table 122. Sichuan Tianji Biopharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Sichuan Tianji Biopharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product
 Table 124. Sichuan Tianji Biopharmaceutical Co., Ltd. Recent Developments/Updates
 Table 125. Sichuan Tongyuan Pharmaceutical Group Co., Ltd. Company Information
 Table 126. Sichuan Tongyuan Pharmaceutical Group Co., Ltd. Description and Business Overview
 Table 127. Sichuan Tongyuan Pharmaceutical Group Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Sichuan Tongyuan Pharmaceutical Group Co., Ltd. Compound Andrographis Paniculata Tablets Product
 Table 129. Sichuan Tongyuan Pharmaceutical Group Co., Ltd. Recent Developments/Updates
 Table 130. Huizhou Daya Pharmaceutical Co., Ltd. Company Information
 Table 131. Huizhou Daya Pharmaceutical Co., Ltd. Description and Business Overview
 Table 132. Huizhou Daya Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Huizhou Daya Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product
 Table 134. Huizhou Daya Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 135. Sichuan Senke Pharmaceutical Co., Ltd. Company Information
 Table 136. Sichuan Senke Pharmaceutical Co., Ltd. Description and Business Overview
 Table 137. Sichuan Senke Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. Sichuan Senke Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product
 Table 139. Sichuan Senke Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 140. Baotou Traditional Chinese Medicine Co., Ltd. Company Information
 Table 141. Baotou Traditional Chinese Medicine Co., Ltd. Description and Business Overview
 Table 142. Baotou Traditional Chinese Medicine Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Baotou Traditional Chinese Medicine Co., Ltd. Compound Andrographis Paniculata Tablets Product
 Table 144. Baotou Traditional Chinese Medicine Co., Ltd. Recent Developments/Updates
 Table 145. Guangxi Jinye Pharmaceutical Co., Ltd. Company Information
 Table 146. Guangxi Jinye Pharmaceutical Co., Ltd. Description and Business Overview
 Table 147. Guangxi Jinye Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 148. Guangxi Jinye Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product
 Table 149. Guangxi Jinye Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 150. Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd. Company Information
 Table 151. Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd. Description and Business Overview
 Table 152. Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 153. Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product
 Table 154. Guangdong Huazhou Traditional Chinese Medicine Factory Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 155. Guangdong Hengcheng Pharmaceutical Co., Ltd. Company Information
 Table 156. Guangdong Hengcheng Pharmaceutical Co., Ltd. Description and Business Overview
 Table 157. Guangdong Hengcheng Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 158. Guangdong Hengcheng Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product
 Table 159. Guangdong Hengcheng Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 160. Henan Lingrui Pharmaceutical Co., Ltd. Company Information
 Table 161. Henan Lingrui Pharmaceutical Co., Ltd. Description and Business Overview
 Table 162. Henan Lingrui Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 163. Henan Lingrui Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product
 Table 164. Henan Lingrui Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 165. Zhongshan Kekekang Pharmaceutical Co., Ltd. Company Information
 Table 166. Zhongshan Kekekang Pharmaceutical Co., Ltd. Description and Business Overview
 Table 167. Zhongshan Kekekang Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 168. Zhongshan Kekekang Pharmaceutical Co., Ltd. Compound Andrographis Paniculata Tablets Product
 Table 169. Zhongshan Kekekang Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 170. Key Raw Materials Lists
 Table 171. Raw Materials Key Suppliers Lists
 Table 172. Compound Andrographis Paniculata Tablets Distributors List
 Table 173. Compound Andrographis Paniculata Tablets Customers List
 Table 174. Compound Andrographis Paniculata Tablets Market Trends
 Table 175. Compound Andrographis Paniculata Tablets Market Drivers
 Table 176. Compound Andrographis Paniculata Tablets Market Challenges
 Table 177. Compound Andrographis Paniculata Tablets Market Restraints
 Table 178. Research Programs/Design for This Report
 Table 179. Key Data Information from Secondary Sources
 Table 180. Key Data Information from Primary Sources
 Table 181. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Compound Andrographis Paniculata Tablets
 Figure 2. Global Compound Andrographis Paniculata Tablets Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Compound Andrographis Paniculata Tablets Market Share by Type: 2025 & 2032
 Figure 4. Film-coated Tablets Product Picture
 Figure 5. Sugar-coated Tablets Product Picture
 Figure 6. Global Compound Andrographis Paniculata Tablets Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Compound Andrographis Paniculata Tablets Market Share by Application: 2025 & 2032
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Other
 Figure 11. Global Compound Andrographis Paniculata Tablets Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Compound Andrographis Paniculata Tablets Market Size (US$ Million), 2021–2032
 Figure 13. Global Compound Andrographis Paniculata Tablets Sales (K Units), 2021–2032
 Figure 14. Global Compound Andrographis Paniculata Tablets Average Price (US$/Unit), 2021–2032
 Figure 15. Compound Andrographis Paniculata Tablets Report Years Considered
 Figure 16. Compound Andrographis Paniculata Tablets Sales Share by Manufacturers in 2025
 Figure 17. Global Compound Andrographis Paniculata Tablets Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Compound Andrographis Paniculata Tablets Players: Market Share by Revenue in Compound Andrographis Paniculata Tablets in 2025
 Figure 19. Compound Andrographis Paniculata Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Compound Andrographis Paniculata Tablets Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Compound Andrographis Paniculata Tablets Sales Market Share by Country (2021–2032)
 Figure 22. North America Compound Andrographis Paniculata Tablets Revenue Market Share by Country (2021–2032)
 Figure 23. United States Compound Andrographis Paniculata Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Compound Andrographis Paniculata Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Compound Andrographis Paniculata Tablets Sales Market Share by Country (2021–2032)
 Figure 26. Europe Compound Andrographis Paniculata Tablets Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Compound Andrographis Paniculata Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Compound Andrographis Paniculata Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Compound Andrographis Paniculata Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Compound Andrographis Paniculata Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Compound Andrographis Paniculata Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Compound Andrographis Paniculata Tablets Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Compound Andrographis Paniculata Tablets Revenue Market Share by Region (2021–2032)
 Figure 34. China Compound Andrographis Paniculata Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Compound Andrographis Paniculata Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Compound Andrographis Paniculata Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Compound Andrographis Paniculata Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Compound Andrographis Paniculata Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Compound Andrographis Paniculata Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Compound Andrographis Paniculata Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Compound Andrographis Paniculata Tablets Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Compound Andrographis Paniculata Tablets Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Compound Andrographis Paniculata Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Compound Andrographis Paniculata Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Compound Andrographis Paniculata Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Compound Andrographis Paniculata Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Compound Andrographis Paniculata Tablets Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Compound Andrographis Paniculata Tablets Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Compound Andrographis Paniculata Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Compound Andrographis Paniculata Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Compound Andrographis Paniculata Tablets Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Compound Andrographis Paniculata Tablets by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Compound Andrographis Paniculata Tablets by Type (2021–2032)
 Figure 54. Global Compound Andrographis Paniculata Tablets Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Compound Andrographis Paniculata Tablets by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Compound Andrographis Paniculata Tablets by Application (2021–2032)
 Figure 57. Global Compound Andrographis Paniculata Tablets Price (US$/Unit) by Application (2021–2032)
 Figure 58. Compound Andrographis Paniculata Tablets Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Andrographis Paniculata Extract Market Insights Forecast to 2030
Global Andrographis Extract Market Insights Forecast to 2030
Global Andrographis Paniculata Tablets Market Research Report 2024
Global Andrographis Paniculana Injection Market Research Report 2024
Global Andrographolide Tablets Market Research Report 2024
Global Neoandrographolide Market Research Report 2024
Global Andrographis Supplement Market Research Report 2024
Global Potassium Dehydroandrographolide Succinate Injection Market Research Report 2025
Global Compound Glycyrrhizin Tablets Market Research Report 2024
Global Andrographolide Market Research Report 2025
Global Compound Aminopeptin Tablets Market Research Report 2024
Global Rhizoma Gastrodiae Tablets Market Research Report 2024
Global Triamcinolone Tablets Market Research Report 2024
Over The Counter Medicines for Sore Throat Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diflunisal Tablets Market Research Report 2024
Global Compound Paracetamol and Amantadine Hydrochloride Tablets Market Research Report 2024
Global Allergy and Sinus Medicine Market Research Report 2025
Global Roxithromycin Tablets Market Research Report 2024
Global Norfloxacin Tablets Market Research Report 2025
Global Medicine Tablet Printer Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions